Vemurafenib

我们是谁

  • 4 月 5, 2022
    The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
  • 4 月 5, 2022
    西妥昔单抗和维莫非尼联合 FOLFIRI 治疗 BRAF V600E 突变的晚期结直肠癌 (IMPROVEMENT)